Evidence map›Paper›PMID 35606927›Full record

ArticleThe British journal of dermatology2022

Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a coincidence.

Mor Pavlovsky, Alon Peled, Ofer Sarig, Nadav Astman, Liron Malki, Odile Meijers, Sari Assaf, Janice Schwartz, Kiril Malovitski, David Hansen and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The British journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. HMCN1 variants aggravate epidermolysis bullosa simplex phenotype.The Journal of experimental medicine · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. The variant c.274A>G (p.Asn92Asp) inFrontiers in genetics · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Mor PavlovskyDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.ORCID 0000-0002-0751-4739
Alon PeledDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.ORCID 0000-0001-6158-1089
Ofer SarigDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.ORCID 0000-0003-2987-2091
Nadav AstmanDepartment of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Liron MalkiDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Odile MeijersDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Sari AssafDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Janice SchwartzPachyonychia Congenita Project, Holladay, UT, USA.
Kiril MalovitskiDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
David HansenPachyonychia Congenita Project, Holladay, UT, USA.
Eli SprecherDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Liat SamuelovDivision of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Tel Aviv University · ILTel Aviv Sourasky Medical Center · ILPachyonychia Congenita Project · USSheba Medical Center · ILUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coexistence of pachyonychia congenita (PC) and hidradenitis suppurativa (HS) has been described in case reports. However, the pathomechanism underlying this association and its true prevalence are unknown.

objectivesTo determine the genetic defect underlying the coexistence of PC and HS in a large kindred, to delineate a pathophysiological signalling defect jointly leading to both phenotypes, and to estimate the prevalence of HS in PC.

methodsWe used direct sequencing and a NOTCH luciferase reporter assay to characterize the pathophysiological basis of the familial coexistence of HS and PC. A questionnaire was distributed to patients with PC registered with the International Pachyonychia Congenita Research Registry (IPCRR) to assess the prevalence of HS among patients with PC.

resultsDirect sequencing of DNA samples obtained from family members displaying both PC and HS demonstrated a missense variant (c.275A>G) in KRT17, encoding keratin 17. Abnormal NOTCH signalling has been suggested to contribute to HS pathogenesis. Accordingly, the KRT17 c.275A>G variant resulted in a significant decrease in NOTCH activity. To ascertain the clinical importance of the association of HS with PC, we distributed a questionnaire to all patients with PC registered with the IPCRR. Seventy-two of 278 responders reported HS-associated clinical features (25·9%). Disease-causing mutations in KRT17 were most prevalent among patients with a dual phenotype of PC and HS (43%).

conclusionsThe coexistence of HS and KRT17-associated PC is more common than previously thought. Impaired NOTCH signalling as a result of KRT17 mutations may predispose patients with PC to HS. What is already known about this topic? The coexistence of pachyonychia congenita (PC) and hidradenitis suppurativa (HS) has been described in case reports. However, the pathomechanism underlying this association and its true prevalence are unknown. What does this study add? A dual phenotype consisting of PC and HS was found to be associated with a pathogenic variant in KRT17. This variant was found to affect NOTCH signalling, which has been previously implicated in HS pathogenesis. HS was found to be associated with PC in a large cohort of patients with PC, especially in patients carrying KRT17 variants, suggesting that KRT17 variants causing PC may also predispose to HS. What is the translational message? These findings suggest that patients with PC have a higher prevalence of HS than previously thought, and hence physicians should have a higher level of suspicion of HS diagnosis in patients with PC.

Indexed as

Hidradenitis SuppurativaPachyonychia CongenitaHumansKeratin-17MutationPhenotypeKeratin-17

Identifiers

PMID35606927
PMCPMC9796395
OpenAlexW4281396275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.